Invention Grant
- Patent Title: Therapeutic use for treating of leukemia
- Patent Title (中): 治疗白血病的治疗用途
-
Application No.: US12485401Application Date: 2009-06-16
-
Publication No.: US08236811B2Publication Date: 2012-08-07
- Inventor: Bernard Bourrie , Pierre Casellas
- Applicant: Bernard Bourrie , Pierre Casellas
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agent R. Brian McCaslin
- Priority: FR0611492 20061228
- Main IPC: A61K31/519
- IPC: A61K31/519
Abstract:
The disclosure relates to methods of treating leukaemia, in particular myeloid leukaemia, comprising administering the compound N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-N′-(1,1-dimethylethyl)-urea or a hydrate, a pharmaceutically acceptable salt or a solvate thereof.
Public/Granted literature
- US20090298790A1 NOVEL THERAPEUTIC USE FOR TREATING OF LEUKEMIA Public/Granted day:2009-12-03
Information query
IPC分类:
